Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma
Clinical trial NCT03890952 · COMPLETED
Trial details
- NCT number
- NCT03890952
- Sponsor
- Ulrik Lassen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2023-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.